Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Q3 2024 Earnings Call Transcript

Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Q3 2024 Earnings Call Transcript October 31, 2024

Alnylam Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $-0.87, expectations were $-0.93.

Operator: Good day, everyone, and welcome to today’s Alnylam Pharmaceuticals Q3 2024 Earnings Conference Call. At this time, all participants are in a listen-only-mode. Later, you will have the opportunity to ask questions during the question-and-answer session. [Operator Instructions] Please...